Results 161 to 170 of about 304,634 (351)

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source

Activity of Bu-zhong-yi-qi-tang (bu zhong yi qi tang) fractions on cyclophosphamide-induced leukopenia in mice

, 2005
Sze-wan Leung
openalex   +1 more source

SAFETY AND EFFICACY OF A LOW DOSE CORTICOSTEROID REGIMEN FOR THE INDUCTION TREATMENT OF LUPUS NEPHRITIS - CYCLONES TRIAL: CYCLOPHOSPHAMIDE LOW DOSE AND NO EXTRA STEROID

, 2021
Michelle Lopes, Sandra Gofinet Pasoto, Emily Figueiredo Neves Yuki, Lorena Elizabeth Betancourt Villamarín, Francisco Fellipe Claudino Formiga, Débora Cordeiro do Rosário, L.M.K.R. Brandão, Carolina Torres Ribeiro, Tatiana do Nascimento Pedrosa, Alex Cardoso Lopes, Eduardo Ferreira Borba, Luciana Parente Costa Seguro, Nádia Emi Aikawa, Eloísa Bonfá   +13 more
openalex   +1 more source

Model‐informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This study aimed to develop and validate a population pharmacokinetic‐pharmacodynamic (pop‐PK‐PD) model to describe carboplatin‐induced myelosuppression in cancer patients and support dose individualization. Methods Data from 580 cancer patients treated with carboplatin at Amsterdam UMC between 2019 and 2022 were used for model ...
Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul, Tim Schutte, Lia van Zuijlen, Idris Bahce, Medhat M. Said, Jan Buter, Harmen Huls, Paolo Magni, Imke Bartelink   +10 more
wiley   +1 more source

Cyclophosphamide and MS

Neurology, 1994
Noseworthy, J, Ebers, G, Roberts, R
openaire   +3 more sources

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Post-Transplant Cyclophosphamide for haematological malignancies: a single centre experience [PDF]

, 2016
Dmitry Motorin, Renat Badaev, Diana Babenetskaya, Nataliya A. Ilyina, Tatyana Silina, Georgiy G. Baratashvili, Vladimir Ivanov, Yuliya A. Alexeeva, Andrey Zaritskey   +8 more
openalex   +1 more source

The effect of acute treatment with cyclophosphamide in post-weaning on stress response and hippocampal stem/progenitor cell proliferation in the adulthood

, 2022
Yusuke Onaka, Taro Yamaguchi, Masanori Yoneyama   +2 more
openalex   +2 more sources

Clinical Images: Methotrexate‐induced melanonychia

Arthritis &Rheumatology, EarlyView.
Yoshinori Taniguchi, Hirotaka Yamamoto
wiley   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

Voclosporin‐induced gingival enlargement: A case report

Clinical Advances in Periodontics, EarlyView.
Abstract Background Drug‐influenced gingival enlargement (DIGE) is a recognized adverse effect of certain medications, particularly immunosuppressants like cyclosporin and tacrolimus. However, there have been no documented cases of DIGE associated with voclosporin, a newer calcineurin inhibitor used primarily to treat lupus nephritis.
Francesca Racca, Jessica M. Greco, Dimitris N. Tatakis   +2 more
wiley   +1 more source